Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis

Saved in:
Bibliographic Details
Published in:Rheumatology Advances in Practice
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301675210899456
collection WordPress RSS
FRELIP Feed Integration
container_title Rheumatology Advances in Practice
description
discipline_display Rheumatology
discipline_facet Rheumatology
format Online Article
RSS Article
genre Journal Article
id rss_article:58279
institution FRELIP
journal_source_facet Rheumatology Advances in Practice
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
Rheumatology
General
Rheumatology
sub_discipline_display General
sub_discipline_facet General
subject_display Rheumatology
General
Rheumatology
Rheumatology
General
Rheumatology
subject_facet Rheumatology
General
Rheumatology
title Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
title_auth Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
title_full Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
title_fullStr Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
title_full_unstemmed Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
title_short Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
title_sort novel use of anifrolumab in a young patient with jo-1-positive juvenile dermatomyositis
topic Rheumatology
General
Rheumatology
url https://academic.oup.com/rheumap/article/doi/10.1093/rap/rkag017/8440775?rss=1